Biodesix Inc (OQ:BDSX)

Business Focus: Medical & Diagnostic Laboratories

Sector:  Healthcare Industry:  Healthcare Facilities & Services
See Regulatory Filings on SEC
Company Contact
Address: Suite 100, 2970 Wilderness Place
Tel: 1-212-9152568
IR: See website
Key People
Scott Hutton
President, Chief Executive Officer, Director
Robin Harper Cowie
Chief Financial Officer, Treasurer, Secretary
Ryan H. Siurek
Chief Accounting Officer
Business Overview
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company's product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
Financial Overview
For the nine months ended 30 September 2022, Biodesix Inc revenues decreased 40% to $28.6M. Net loss increased 51% to $45.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Sales, marketing, general and administ increase of 22% to $41.3M (expense), Loss on extinguishment of liabilities increase from $2.4M (income) to $3M (expense).
Employees: 218 as of Dec 31, 2021
Reporting Currency: U.S. Dollars
Enterprise value: $113.72M as of Sep 30, 2022
Annual revenue (TTM): $35.83M as of Sep 30, 2022
EBITDA (TTM): -$44.72M as of Sep 30, 2022
Net annual income (TTM): -$58.39M as of Sep 30, 2022
Free cash flow (TTM): -$45.41M as of Sep 30, 2022
Net Debt Last Fiscal Year: $4.04M as of Sep 30, 2022
Shares outstanding: 71,685,532 as of Nov 16, 2022
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.